Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3350
-0.0050 (-1.47%)
At close: Jul 31, 2025
Accolade Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 10.19 | 8.57 | 11.35 | 6.85 | 6.16 | Upgrade |
Depreciation & Amortization | 3.06 | 2.8 | 2.72 | 2.2 | 2.08 | Upgrade |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | 0 | 0 | -0 | Upgrade |
Loss (Gain) From Sale of Investments | - | -0.17 | - | - | - | Upgrade |
Loss (Gain) on Equity Investments | - | -0.55 | -0.47 | -0.02 | - | Upgrade |
Other Operating Activities | 1.3 | -0.77 | 1.13 | 0.47 | -0.3 | Upgrade |
Change in Accounts Receivable | -4.18 | -9.24 | -2.56 | -1.99 | -0.77 | Upgrade |
Change in Inventory | -8.92 | -3.52 | 4.03 | -4.61 | -5.46 | Upgrade |
Change in Accounts Payable | -0.92 | 9.65 | 0.84 | 3.11 | 2.61 | Upgrade |
Change in Other Net Operating Assets | -0.47 | -1.13 | -0.17 | 0.02 | -0.2 | Upgrade |
Operating Cash Flow | 0.06 | 5.65 | 16.88 | 6.04 | 4.13 | Upgrade |
Operating Cash Flow Growth | -98.94% | -66.55% | 179.51% | 46.20% | -56.31% | Upgrade |
Capital Expenditures | -1.18 | -0.3 | -0.56 | -0.7 | -0.37 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0 | - | 0.01 | Upgrade |
Cash Acquisitions | - | -0.75 | 0.18 | -14.16 | - | Upgrade |
Sale (Purchase) of Intangibles | -2 | -0.9 | -0.76 | -0.13 | -0.83 | Upgrade |
Investment in Securities | - | - | 0.03 | - | - | Upgrade |
Other Investing Activities | 0.15 | 0.46 | 0.1 | 0.07 | 0.18 | Upgrade |
Investing Cash Flow | -3.02 | -1.48 | -1.01 | -14.92 | -1.01 | Upgrade |
Long-Term Debt Issued | 9.01 | - | 5 | 4.24 | 2.44 | Upgrade |
Long-Term Debt Repaid | -2.82 | -2.5 | -7.64 | -1.47 | -1.08 | Upgrade |
Net Debt Issued (Repaid) | 6.19 | -2.5 | -2.64 | 2.77 | 1.36 | Upgrade |
Repurchase of Common Stock | -0.09 | - | - | - | - | Upgrade |
Common Dividends Paid | -2.66 | -14.56 | -2.07 | -1.86 | -3 | Upgrade |
Other Financing Activities | -0.44 | -0.21 | 5.86 | -0.1 | -0.11 | Upgrade |
Financing Cash Flow | 3.01 | -17.28 | 1.15 | 0.81 | -1.76 | Upgrade |
Net Cash Flow | 0.05 | -13.11 | 17.02 | -8.07 | 1.36 | Upgrade |
Free Cash Flow | -1.12 | 5.34 | 16.32 | 5.34 | 3.76 | Upgrade |
Free Cash Flow Growth | - | -67.27% | 205.77% | 41.98% | -58.00% | Upgrade |
Free Cash Flow Margin | -0.57% | 3.13% | 10.05% | 4.24% | 3.11% | Upgrade |
Free Cash Flow Per Share | -0.00 | 0.02 | 0.05 | 0.02 | 0.01 | Upgrade |
Cash Interest Paid | 0.34 | 0.21 | 0.24 | 0.1 | 0.11 | Upgrade |
Cash Income Tax Paid | 2.35 | 2.6 | 2.15 | 1.42 | 1.06 | Upgrade |
Levered Free Cash Flow | -7.03 | 2.01 | 14.57 | -0.74 | -0.03 | Upgrade |
Unlevered Free Cash Flow | -6.68 | 2.18 | 14.71 | -0.68 | 0.03 | Upgrade |
Change in Net Working Capital | 14.57 | 6.52 | -3.95 | 7.1 | 3.92 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.